| MolName | (E)-N-[5-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide |
| MolecularFormula | C22H22N4O2S2 |
| Smiles | Cc(cc1C)cc(C)c1NC(CSc1nnc(NC(/C=C/c2ccccc2)=O)s1)=O |
| InChI | InChI=1S/C22H22N4O2S2/c1-14-11-15(2)20(16(3)12-14)23-19(28)13-29-22-26-25-21(30-22)24-18(27)10-9-17-7-5-4-6-8-17/h4-12H,13H2,1-3H3,(H,23,28)(H,24,25,27) |
| InChIK | RZLJHHPKFJZOCC-UHFFFAOYSA-N |
| TotalMolweight | 438.575 |
| Molweight | 438.575 |
| MonoisotopicMass | 438.118416 |
| CLogP | 4.866 |
| CLogS | -6.363 |
| H Acceptors | 6 |
| H Donors | 2 |
| TotalSurfaceArea | 339.19 |
| Relative PSA | 0.32073 |
| PolarSurfaceArea | 137.52 |
| Druglikeness | 1.8914 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.66667 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 7 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 5 |
| Symmetricatoms | 5 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (E)-N-[5-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide | 2 - (E)-N-[5-[2-oxo-2-(2,4,6-trimethylanilino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide